BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27056328)

  • 1. Role of Prion Replication in the Strain-dependent Brain Regional Distribution of Prions.
    Hu PP; Morales R; Duran-Aniotz C; Moreno-Gonzalez I; Khan U; Soto C
    J Biol Chem; 2016 Jun; 291(24):12880-12887. PubMed ID: 27056328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain-dependent profile of misfolded prion protein aggregates.
    Morales R; Hu PP; Duran-Aniotz C; Moda F; Diaz-Espinoza R; Chen B; Bravo-Alegria J; Makarava N; Baskakov IV; Soto C
    Sci Rep; 2016 Feb; 6():20526. PubMed ID: 26877167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host Determinants of Prion Strain Diversity Independent of Prion Protein Genotype.
    Crowell J; Hughson A; Caughey B; Bessen RA
    J Virol; 2015 Oct; 89(20):10427-41. PubMed ID: 26246570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-genetic propagation of strain-specific properties of scrapie prion protein.
    Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
    Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions.
    Castilla J; Gonzalez-Romero D; Saá P; Morales R; De Castro J; Soto C
    Cell; 2008 Sep; 134(5):757-68. PubMed ID: 18775309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
    Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
    PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.
    Shikiya RA; Eckland TE; Young AJ; Bartz JC
    Prion; 2014; 8(6):415-20. PubMed ID: 25482601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of Prion Strain Emergence by Nonhost Factors.
    Holec SAM; Yuan Q; Bartz JC
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coinfecting prion strains compete for a limiting cellular resource.
    Shikiya RA; Ayers JI; Schutt CR; Kincaid AE; Bartz JC
    J Virol; 2010 Jun; 84(11):5706-14. PubMed ID: 20237082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incongruity between Prion Conversion and Incubation Period following Coinfection.
    Langenfeld KA; Shikiya RA; Kincaid AE; Bartz JC
    J Virol; 2016 Jun; 90(12):5715-23. PubMed ID: 27053546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent amplification of co-infected long incubation period low conversion efficiency prion strains.
    Eckland TE; Shikiya RA; Bartz JC
    PLoS Pathog; 2018 Oct; 14(10):e1007323. PubMed ID: 30335854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
    Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
    PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly efficient protein misfolding cyclic amplification.
    Gonzalez-Montalban N; Makarava N; Ostapchenko VG; Savtchenk R; Alexeeva I; Rohwer RG; Baskakov IV
    PLoS Pathog; 2011 Feb; 7(2):e1001277. PubMed ID: 21347353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein.
    Makarava N; Savtchenko R; Lasch P; Beekes M; Baskakov IV
    Acta Neuropathol Commun; 2018 Sep; 6(1):92. PubMed ID: 30208966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of strain-specific PrP(Sc) elongation rates revealed a transformation of PrP(Sc) properties during protein misfolding cyclic amplification.
    Gonzalez-Montalban N; Baskakov IV
    PLoS One; 2012; 7(7):e41210. PubMed ID: 22815972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion strain targeting independent of strain-specific neuronal tropism.
    Ayers JI; Kincaid AE; Bartz JC
    J Virol; 2009 Jan; 83(1):81-7. PubMed ID: 18971281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
    Phuan PW; Zorn JA; Safar J; Giles K; Prusiner SB; Cohen FE; May BCH
    J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.